Ultralife Q2 Adj EPS $0.29 Beats $0.04 Estimate, Sales $42.70M Beat $32.00M Estimate
Portfolio Pulse from Benzinga Newsdesk
Ultralife Corporation (NASDAQ:ULBI) reported Q2 adjusted earnings of $0.29 per share, beating the analyst consensus estimate of $0.04 by 625%. This is a 866.67% increase from the same period last year. The company also reported quarterly sales of $42.70 million, beating the analyst consensus estimate of $32.00 million by 33.44%, a 32.91% increase from the same period last year.
July 27, 2023 | 11:01 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ultralife Corporation reported significantly higher Q2 earnings and sales than expected, which could positively impact its stock price.
Ultralife Corporation's Q2 earnings and sales significantly exceeded analyst estimates, which is typically a positive signal for the stock price. The substantial YoY growth in earnings and sales also indicates strong financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100